Q2 2024 Medicine Man Technologies Inc Earnings Call Transcript
Key Points
- Medicine Man Technologies Inc (SHWZ) is actively gaining market share in competitive markets like Colorado and New Mexico.
- The company reported a 6% growth in Colorado despite an 11% market decline, showcasing strong operational performance.
- Wholesale penetration increased significantly in both Colorado and New Mexico, indicating successful expansion efforts.
- The company has implemented strategic initiatives to optimize cultivation and manufacturing, including the use of new LED lights to improve yield.
- Medicine Man Technologies Inc (SHWZ) successfully restructured debt, extending maturities to November 2025, providing financial flexibility for growth initiatives.
- Gross profit decreased from 54% to 44% year-over-year, primarily due to pricing pressure and a greater mix of third-party purchasing.
- Operating expenses increased to $21.8 million from $18.1 million, driven by costs associated with additional stores and nonrecurring professional service fees.
- The company reported a loss from operations of $2.7 million compared to income from operations of $5 million in the previous year.
- Medicine Man Technologies Inc (SHWZ) faced challenges with delayed SEC filings, resulting in a transition to the OTC Expert Market.
- Three underperforming dispensaries in Colorado were closed as part of a restructuring initiative, indicating challenges in maintaining profitability across all locations.
Good afternoon. My name is Joe, and I will be your conference operator today. At this time, I would like to welcome everyone to Schwazze's second-quarter 2024 conference call. (Operator instructions) Following their prepared remarks, management will take questions submitted via the web link found on Schwazze's investor relations website and in the earnings press release. Please also note that today's conference call is being recorded.
I would now like to hand the conference over to the company's external Head of Investor Relations, Sean Mansouri, with Elevate IR. Sir, please go ahead.
Thank you. Good afternoon, everyone, and welcome to Schwazze's second-quarter 2024 earnings conference call. Joining me on the call are Forrest Hoffmaster, Interim Chief Executive Officer and Chief Financial Officer; and Justin Dye, Chairman of the Board. The company will begin with prepared remarks, and then we will open the call for Q&A.
I would like to remind you that management's prepared remarks and answers to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
